| 2010-07-30 |
Nycomed International Management GmbH - Strategic Analysis Review |
GlobalData |
| 2010-07-01 |
Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016 |
GlobalData |
| 2008-06-11 |
Vernalis plc: Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile |
Datamonitor |
| 2008-05-01 |
Cardiotoxicity: Issues, Technologies, and Solutions for the Future |
CHI Insight Pharma Reports |
| 2008-04-20 |
Antibodies in Oncology: Drug Pipeline Update 2008 |
BioSeeker Group AB |
| 2008-04-20 |
Apoptosis in Oncology: Drug Pipeline Update 2008 |
BioSeeker Group AB |
| 2008-04-20 |
Immunotherapy in Oncology: Drug Pipeline Update 2008 |
BioSeeker Group AB |
| 2008-04-20 |
Brain Cancer Drug Pipeline Update 2008 |
BioSeeker Group AB |
| 2008-04-20 |
Cancer Vaccines: Drug Pipeline Update 2008 |
BioSeeker Group AB |
| 2006-08-01 |
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis |
Drug and Market Development Publishing |
| 2006-06-01 |
Transmembrane Transporters: High Sales, High Potential as Drug Targets |
Drug and Market Development Publishing |
| 2006-05-15 |
Promising New Approaches for Discovering Ion-Channel Modulators |
Decision Resources |
| 2006-05-01 |
Ventricular Fibrillation and Atrial Fibrillation : Emerging Antiarrhythmics In The Context of Current Devices, Interventions and Pharmacological Agents |
LeadDiscovery |
| 2006-01-23 |
Conference Documentation: High Throughput Screening |
SMI Publishing, Ltd |
| 2004-05-11 |
Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress |
BioSeeker Group AB |
| 2002-11-07 |
Ion Channel Assays as Therapeutic Targets for Multiple Diseases |
BioSeeker Group AB |
| 2002-11-07 |
Ion Channels as Therapeutic Targets for Multiple Diseases |
BioSeeker Group AB |
| 2002-06-03 |
Ion Channel Assays in the Drug Discovery Process |
BioSeeker Group AB |
